跳至主要内容
临床试验/ISRCTN79058224
ISRCTN79058224已完成未知

Monitoring for neovascular AMD reactivation at home: the MONARCH study

The Queen's University Belfast0 个研究点目标入组 297 人开始时间: 2017年10月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
297

研究概览

简要总结

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32367004/ protocol (added 05/10/2020) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38453199/ (added 08/03/2024) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39023220/ (added 19/07/2024)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Current participant inclusion criteria as of 05/08/2019:
  • 1. Aged =50 years old
  • 2. At least one eye meeting ALL the inclusion criteria for a study eye
  • 2.1. Eye first treated for active nAMD = 6 months ago
  • 2.2. Eye first treated for active nAMD not more than 42 months ago
  • 2.3. Eye currently being monitored for nAMD disease by the NHS
  • Previous participant inclusion criteria:
  • 1. Patients =50 years old diagnosed with active nAMD (= 6 months earlier) and currently being treated with an anti-VEGF drug or monitored (i.e. with active or inactive nAMD) by the NHS
  • 2. Within 42 months of first treatment for nAMD

排除标准

  • Current participant exclusion criteria as of 05/08/2019:
  • 1. Vision in the eye being monitored limited by another eye condition
  • 2. Surgery in the study eye in the previous 6 months
  • 3. Refractive error in the eye being monitored >-6D
  • 4. Retinal or choroidal neovascularization in the eye being monitored not due to nAMD
  • 5. Inability to do one or more of the proposed tests as assessed during ‘further information and training’ session
  • 6. Unable to understand English
  • 7. Unable to comply with proposed home testing
  • 8. Vision is worse than Snellen score 6/60, LogMar 1.04 or 33 letters
  • Previous participant exclusion criteria:
  • 1. Vision in the eye being monitored limited by another eye condition
  • 2. Surgery in the study eye in the previous 6 months
  • 3. Refractive error in the eye being monitored >-6D
  • 4. Retinal or choroidal neovascularization in the eye being monitored not due to nAMD
  • 5. Inability to do one or more of the proposed tests as assessed during ‘further information and training’ session
  • 6. Unable to understand English
  • 7. Unable to comply with proposed home testing

研究者

发起方
The Queen's University Belfast

相似试验